TREM2 ANTIBODIES AND USES THEREOF
Application
US20260092111A1
Kind: A1
Apr 02, 2026
Inventors
Michael FASSLER, Jacob GEORGE
Abstract
The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). The anti-TREM2 antibodies or antigen-binding fragments thereof are useful, for example, in detecting TREM2 and in treating neurodegenerative diseases.
CPC Classifications
C07K 16/2803
A61P 25/28
A61P 29/00
A61K 2039/505
C07K 2317/24
C07K 2317/565
C07K 2317/76
C07K 2317/92
Filing Date
2025-06-10
Application No.
19234052